Coronavirus Tax Assistance:

Under the COVID-19 stimulus package, formally titled the Coronavirus Aid Relief and Economic Security Act (“CARES Act”), which the President signed into law on March 27, 2020, taxpayers who have been unable to carry back net operating losses originating after 2017 based on recent changes to the Internal Revenue Code (“IRC”) have been provided substantial relief.

Specifically, under newly enacted IRC § 172(b)(1)(D), taxpayers may now carry back net operating losses (NOLs) arising in any tax year beginning after December 31, 2017 and ending before January 1, 2021, to each of the 5 preceding tax years. This revision to § 172 expressly (if temporarily) revokes a provision of the Tax Cut and Jobs Act of 2017 (TCJA) which barred NOL carrybacks (instead allowing only NOL carryforwards) for most taxpayers.

Background

Prior to the TCJA, taxpayers were generally permitted to carry back NOLs (that is, the excess of deductible losses over gross income in a given tax year, subject to certain modifications) 2 years from the year of origination, and then carry them forward another 20 years.  The carryback or carryforward of NOLs potentially allowed taxpayers to use a current year loss to generate a refund of tax paid in an earlier or later year.  For a simplified example, assume that in Year 1 a taxpayer has taxable income of $100,000 and pays tax of $35,000 based on a flat tax rate of 35 percent.  In Year 3, the taxpayer generates an NOL of $50,000.  Under the pre-TCJA rules, the taxpayer could apply its $50,000 Year 3 NOL retroactively to Year 1, thereby reducing Year 1 taxable income to $50,000 and generating a refund of $17,500 (that is, half of the tax paid in Year 1).

The policy underlying NOL carrybacks and carryforwards is to smooth out the peaks and valleys of the business cycle and more closely align a taxpayer’s tax obligations with the taxpayer’s economic performance over an extended period of time.  If a taxpayer was very profitable in one year, but suffered losses in succeeding years, the taxpayer could carryback its NOLs to the profitable year and recoup some or all of the tax it had previously paid, thereby creating a truer picture of the taxpayer’s economic performance, and resulting tax obligations, over that period of time.

However, effective for the 2018 tax year and forward, the TCJA eliminated the ability for most taxpayers to carryback NOLs (although it did allow for unlimited NOL carryforwards, as opposed to the 20 year carryforward allowed under prior law).  The effect of the TCJA was especially harsh for taxpayers anticipating the carryback of losses arising in 2018 or 2019 to offset income and generate refunds of tax paid in prior years.  Moreover, in circumstances of a sharp economic decline, like the one the country may be facing, the ability to carry back NOLs is crucial because it is more likely that tax was paid in the immediate past, and it is less likely that tax (or a similar amount of tax) will be paid in the immediate future.  Therefore, the most effective refund-generation efforts will be retrospective rather than prospective.

CARES Act Changes

Under the CARES Act, notwithstanding the limitations of the TCJA, all taxpayers may carry back NOLs arising in tax years beginning after December 31, 2017 and before January 1, 2021 (which therefore includes calendar years 2018, 2019, and 2020) to each of the 5 previous tax years.  For instance, if a taxpayer generated an NOL in 2019, that loss can now be carried back to 2014 and then carried forward through 2015, 2016, etc. until the NOL is fully depleted, whereas under prior law the 2019 loss could only be carried forward to 2020, 2021, etc.  To the extent the taxpayer paid tax in those earlier years, the taxpayer may be able to file a refund claim (most likely through the filing of an amended return for the appropriate year) and recoup some of the tax previously paid.

Alternatively, a taxpayer may waive the five-year carryback with respect to NOLs originating in tax years beginning in 2018 or 2019, and choose instead to use an NOL going forward only.  This approach may be preferred by new businesses, businesses which expect an uptick in income in future years, or taxpayers who haven’t paid a substantial amount of tax during the 5-year lookback window.  The procedures and time limitations for making this election are set forth in IRS Rev. Proc. 2020-24.

Note that the TCJA generally limited NOL deductions to 80 percent of the taxpayer’s taxable income in the carryback or carryforward year with respect to NOLs arising after December 31, 2017.  Under the CARES Act modifications, the 80 percent cap is eliminated for carrybacks or carryforwards to tax years beginning prior to January 1, 2021.  However, the 80 percent cap remains effective for all NOLs carried forward to 2021 or later years, even if the subject NOL originated in 2018, 2019, or 2020.

The changes to IRC § 172 discussed in this blog are reminiscent of Congress’s response to prior economic downturns.  For instance, following the 2008 financial panic and subsequent decline in the U.S. economy, Congress extended the usual 2-year carryback to a period of up to 5 years for losses originating in 2008 or 2009.  One notable difference is that in the 2009 law, taxpayers were given the option of expanding the carryback period to 3, 4, or 5 years, whereas the CARES Act allows only a 5 year carryback period.

Summary

Unfortunately, after years of economic expansion, many individuals and businesses will suffer economically in 2020 due to the COVID-19 pandemic.  In addition to other relief measures passed by Congress, the changes to IRC § 172 outlined in this article will allow taxpayers who suffer economic losses in 2020 (or suffered them in 2018 or 2019) to recover some of the tax they paid in more prosperous times.  If you or your business have incurred net operating losses in 2018 or 2019, or anticipate incurring one 2020, you should discuss this opportunity with your tax professionals to ensure you maximize the benefits made available under the CARES Act.

 

 

 

 

The Families First Coronavirus Response Act

The Families First Coronavirus Response Act

On March 18, 2020, in response to the international pandemic caused by the novel Coronavirus, the President signed the “Families First Coronavirus Response Act” (“the Act”). The Act will go into effect on April 20, 2020 and will be the temporary law of the land through December 31, 2020. Summarily, the Act provides free Coronavirus (“COVID-19”) testing, increased funding for various government programs, a new entitlement to temporary emergency paid sick leave, and an expansion of the existing Family Medical Leave Act (“FMLA”). This blog focuses on the sick leave and FMLA provisions of the Act.

Temporary Emergency Paid Sick Leave

As it relates to temporary emergency paid sick leave, the Act only applies to businesses who employ more than 50, but less than 500 workers.[1] The Act states that these employers must provide two-weeks of paid sick leave to employees who are unable to work or telework as a result of any of the following:

  1. The employee is subject to a government quarantine or isolation order related to COVID-19;
  2. The employee has been medically advised to self-quarantine due to COVID-19;
  3. The employee has symptoms of COVID-19 and is seeking testing;
  4. The employee is caring for someone who has been quarantined due to COVID-19;
  5. The employee needs to care for a child whose school or daycare is closed or whose childcare provider is unavailable due to COVID-19; or
  6. The employee is experiencing any other substantially similar condition as specified by the Secretary of Health and Human Services.

 

While the provisions of the Act inure to the benefit of full-time and part-time employees alike, its application impacts these individuals differently. For example, full time employees must be offered eighty (80) hours of paid sick leave, while part-time employees must be provided sick leave that is equivalent to their standard schedule over a two-week period. Leave will be paid at the employee’s regular rate of pay, with certain upper limit caps. More specifically, the most any full time employee may receive is $511 per day, which, over a 10 day period, equals a maximum benefit of $5,110. This upper limit corresponds with the upper limit tax credits that will be available to offset these costs. Further, sick leave pay is limited to two-thirds (or 66.6%) of an employee’s standard rate of pay if the employee qualifies for sick leave only under criteria 4, 5, or 6 above. Employees who qualify for the reduced pay are capped at $200 per day, which, over a 10 day period, equals a maximum benefit of $2,000. Of potential salience, the paid sick leave allotment is supplemental to existing sick leave policies already offered by employers.

Temporary Family Medical Leave Act Expansion

The FMLA has been in place since 1993 and, summarily, provides up to 12 weeks of unpaid leave only to employees who (a) work for a company of 50 or more employees and (b) have been employed at their company for at least 12 months (and worked at least 1250 hours during the prior 12 months). Standard FMLA leave can be used for the birth or adoption of a child, a serious health condition that makes an employee unable to perform the functions of their job, or to care for a close relative with a serious health condition. The Act now expands the reach of the FMLA.

Now, FMLA leave is available to employees who work for any employer of less than 500 employees and who have been employed for at least 30 days. That said, it’s worth mentioning that FMLA leave under the new framework is available for one purpose; that is, to allow employees to care for their children who are under the age of 18 and whose school or place of care has closed due to the COVID-19 public health emergency. Under the new (albeit, temporary) framework, a qualifying employee may take up to 12 weeks of leave. The first 10 days of leave are unpaid, but the employee may elect to use accrued paid sick leave and/or vacation during this otherwise unpaid period. After the initial 10 day period, an employee is entitled to receive two-thirds (or 66.6%) of their normal wages for the number of hours they would be regularly scheduled to work, up to a maximum of $200 per day ($10,000 in total). Along with the emergency paid sick leave provisions noted above, employers will be provided refundable tax credits against their employer portion of Social Security taxes for 100% of the qualified sick leave and family leave wages paid in accordance with the Act. In addition, an employee returning from leave is entitled to reinstatement to the same (or an equal position) they held prior to the temporary absence.

The attorneys at Fuerst Ittleman David & Joseph have extensive experience interpreting regulations and policies and advising both employers and employees on their impact. We will continue to monitor developments in this rapidly changing area of the law and guide our clients through this difficult and uncertain time. If you have any questions, an attorney can be reached by emailing us at contact@fidjlaw.com or by calling 305.350.5690. Stay healthy, safe, and sane.

[1] Many commentators expect that Congress will likely pass similar legislation pertaining to larger businesses employing over 500 workers, but for the time being, mounting social pressure is the only stimulus motiving such employers to act.

Contracts in the Time of Coronavirus:

Part III: UCC Excuses for Nonperformance

As the world continues to confront a prolonged battle with the coronavirus pandemic, the long-term impacts on business and contractual relationships become more and more visible. Business owners in countless industries may be faced with labor and supply shortages, as well as government intervention such as quarantines or emergency shelter-in-place orders, which will render non-performance of contractual duties ever the more likely. Despite the pandemic, contracts still remain valid and enforceable, and parties still face liability for breaching duties they owe pursuant to those contracts. However, those faced with the difficult decisions of how to fulfill contractual obligations in these unprecedented conditions may be able to excuse their performance under several doctrines of nonperformance. In this multipart series, the commercial litigation attorneys of FIDJ explore various doctrines which may excuse performance of contractual obligations.

In Part I of our series, we discussed the potential application of force majeure clauses to excuse nonperformance. In Part II, we discussed the common law doctrines of impossibility and frustration of purpose, which, depending upon the circumstances, may excuse contractual nonperformance. Part III of this series explores excuses for nonperformance which may be available to parties under the Uniform Commercial Code Article 2 (“UCC”) for contracts concerning the sale of goods.

Generally, domestic contracts for the sale of goods are governed by the Uniform Commercial Code as codified by the various states. Florida’s version of the UCC has been codified at Chapter 672, Florida Statutes. UCC § 2-615 (codified at Fla. Stat. § 672.615), titled “Excuse by Failure of Presupposed Conditions” codifies the doctrine of commercial impracticability and may provide sellers of goods relief from performance.

As the comments to 672.615 explain, the “section excuses a seller from timely delivery of goods contracted for, where his performance has become commercially impracticable because of unforeseen supervening circumstances not within the contemplation of the parties at the time of contracting.” Fla. Stat. § 672.615, cmt. 1. Section 672.615 provides in pertinent part:

Except so far as a seller may have assumed a greater obligation and subject to the preceding section on substituted performance:

(1) Delay in delivery or nondelivery in whole or in part by a seller who complies with subsections (2) and (3) is not a breach of her or his duty under a contract for sale if performance as agreed has been made impracticable by the occurrence of a contingency the nonoccurrence of which was a basic assumption on which the contract was made or by compliance in good faith with any applicable foreign or domestic governmental regulation or order whether or not it later proves to be invalid.

For Fla. Stat. § 672.615 to apply, the following conditions must be met.

First, the provision can apply to sale of goods contracts “except so far as a seller may have assumed a greater obligation” concerning the risk of loss of the goods. In instances where sellers contractually assumed the risk for loss in all instances, or have done so through the parties’ previous course of dealings, courts will more likely find that 672.615 does not provide an excuse to nonperformance. See Fla. Stat. § 672.615, cmt. 8.

Second, the occurrence of the event which prevented nonperformance must be either: i) “a contingency the nonoccurrence of which was a basic assumption on which the contract was made;” or ii) seller’s compliance with a supervening “applicable foreign or domestic governmental regulation or order.” Fla. Stat. § 672.615(1). In instances where “the contingency in question is sufficiently foreshadowed at the time of contracting,” 672.615 will not provide relief to sellers. Fla. Stat. § 672.615, cmt, 8. Of course, as with the previous doctrines discussed in this series, foreseeability is a fact intensive inquire and will vary depending upon the circumstances.

Third, the seller’s performance must be made “impracticable.” Fla. Stat. § 672.615(1). Sellers should note that the comments recognize the doctrine of “commercial impracticability” as distinct from common law doctrines of impossibility and frustration of purpose. Fla. Stat. § 672.615, cmt. 3. This is because the doctrine does not require impossibility of performance from the seller or buyer. However, while technically the commercial impracticability defense is an easier defense to assert, it is by no means a guaranteed win.

As comment 4 explains, “[i]ncreased cost alone does not excuse performance unless the rise in cost is due to some unforeseen contingency which alters the essential nature of the performance.” However,  “a severe shortage of raw materials or of supplies due to a contingency such as war, embargo, local crop failure, unforeseen shutdown of major sources of supply or the like, which either causes a marked increase in cost or altogether prevents the seller from securing supplies necessary to his performance, is within the contemplation of this section.” Fla. Stat. § 672.615, cmt. 4.

With regard “supervening” changes in the law which render performance impracticable, “governmental interference cannot excuse [nonperformance] unless it truly ‘supervenes’ in such a manner as to be beyond the seller’s assumption of risk.” Fla. Stat. § 672.615, cmt. 10.

We also note that even if a seller satisfies the conditions necessary under subsection one, excuse will only occur if a seller complies with subsections two and three of the statute. Subsection two requires that if a seller’s partial performance is possible, then a seller “must allocate production and deliveries among his or her customers…in any manner which is fair and reasonable.” Fla. Stat. §672.615(2). “An excused seller must fulfill his contract to the extent which the supervening contingency permits, and if the situation is such that is customers are generally affected he must take account of all in supplying one.” Fla. Stat. § 672.615, cmt. 11.

Finally, subsection three requires sellers to “seasonably” notice buyers that there will be delay or nondelivery and, when allocation is required under subsection (2), of the estimated quota made available for the buyer. Fla. Stat. § 672.615(3). The UCC defines seasonable notice as notice “taken at or within the time agreed or, if no time is agreed, at or within a reasonable time.” Fla. Stat. § 671.204(2). However, whether a time is reasonable depends on the nature, purpose, and circumstances of the action. Id. at (1).

Fuerst Ittleman David & Joseph was founded with a focus on serving the legal needs of domestic and international businesses of all shapes and sizes. Our commercial litigation practice group has decades of experience litigating a wide array of business disputes in state and federal courts as well as domestic and international arbitration panels. In addition, our corporate transactional team can assist your company with a full range of corporate legal services which can take you (and your company) from the initiation of your business plan through the daily operation of your now-thriving company. For more information contact us at 305-350-5690 or info@fidjlaw.com.

Coronavirus Stories We’re Following

Even as expanding corridors of the world are sheltering in place to “flatten the curve” of the Coronavirus, many sectors of the international economy continue to operate, albeit differently than ever before. Many sectors of the economy that perhaps did not realize how important they were in years past are now “essential,” while others who perhaps previously thought they were essential are now anything but essential, and must sit and watch as their valuations plummet.

For us, business continues, and we still have deadlines even though most courts are only operating remotely. Similarly, state and federal governments are dramatically shifting regulatory and enforcement priorities to respond to the pandemic, and our clients in regulated industries still seek our advice regarding their short and long term strategies.

Here are some resources we’re finding useful as we make our own go-forward plans:

Ramsey Villalon from Mamone Villalon in Miami has prepared an excellent synopsis of the CARES Act: https://mamonevillalon.com/update-on-passage-of-cares-act-or-phase-iii-legislation/. Ramsey will update his website with further developments, and we will include Ramsey’s updates here as well.

A helpful summary of Federally Guaranteed Forgivable Business Loans is available here.

IRS’s Coronavirus Tax Relief page is available here.

The American Bankers Association has published an extensive list of the relief packages being  offered by most major financial institutions in the U.S. The list is available here.

Here are some of the stories we’re watching relevant to our own practice in this unprecedented event:

FDA

FDA is at the epicenter of the universe, tasked by law with the monitoring, study and approval of the drugs, tests, vaccines and other medical supplies the nation will need to respond to the Coronavirus. Here are some of its recent actions:

FDA has issued an Emergency IND for convalescent plasma collected from patients who have recovered from the Coronavirus to be used on others. FDA explains how doctors can apply for permission to participate in the Emergency IND here.

FDA has issued an Emergency Use Authorization to allow for the emergency use in health care settings of certain ventilators, anesthesia gas machines modified for use as ventilators, and positive pressure breathing devices modified for use as ventilators (collectively referred to as “ventilators”), ventilator tubing connectors, and ventilator accessories that the FDA determines meet specified criteria for safety, performance and labeling. More information is available here.

Abbott Laboratories and Cepheid have received emergency authorization to manufacture and market rapid Coronavirus tests, which will be on the market soon and can detect the virus patients in minutes. Read more about it in the WSJ here.

The CARES Act included $80M in funding for FDA in its response to the Coronavirus, and significantly modernized the way over-the-counter drugs are regulated in the US. FDA’s comments on both issues are available here.

Telemedicine/Telehealth

Perhaps the greatest benefactor of the Coronavirus crisis is the telemedicine industry. Telemedicine allows for remote medical consultations, saving patients the time, cost and risk of seeing a doctor in person. This is particularly important while our nation’s healthcare system responds to the Coronavirus, but we expect the expanded use of telemedicine to never go away. Telemedicine, generally, is regulated by CMS (to the extent a federal payor is involved), FDA (to the extent the technologies allowing for remote consultations are medical devices), state laws (practice of medicine, standard of care) and other important sources of authority. Here are some of the ongoing developments in the Telemedicine industry:

The federal government has expanded Medicare telehealth coverage that will enable beneficiaries to receive a wider range of healthcare services from their doctors without having to travel to a healthcare facility

CMS is showing unprecedented flexibility in its regulation of the provision of health care in the United States: The increased scope-of-practice flexibility was just one of several regulation relaxations that CMS announced on Monday. “We’re waiving a wide and unprecedented range of regulatory requirements to equip the American healthcare system with maximum flexibility to deal with an influx of cases.”

The CMS Telemedicine Toolkit is available here.

CMS has also added 85 more Medicare services which can now be provided and reimbursed with Medicare Coverage. Lists and codes available here.

From Regenexx.com: Telemedicine in the Time of Corona

From Regenexx.com: How will The Virus Change Healthcare Forever

Litigation

The Eden Roc hotel in Miami Beach has been sued for $2.3M for failing to refund a down payment for a group of 1200 guests who planned an April trip that they now cannot attend. Reporting from the Miami Herald available here.

The Florida Supreme Court has entered numerous orders relating to litigation across the state. The orders are available here.

Florida Business Litigation Update:

On March 25, 2020, the Third DCA issued its panel decision in Island Travel & Tours, Ltd. v. MYR Indep., Inc., 3D16-1364, 2020 WL 1451990, at *3 (Fla. 3d DCA Mar. 25, 2020), which reaffirmed application of the independent tort doctrine to bar common law tort claims in business litigation cases where there is already a contract between the parties.

The independent tort doctrine provides that “[w]here a contract exists, a tort action will lie for either intentional or negligent acts considered to be independent from acts that breached the contract.” HTP, Ltd. v. Lineas Aereas Costarricenses, S.A., 685 So. 2d 1238, 1239 (Fla. 1996). “It is only when the breach of contract is attended by some additional conduct which amounts to an independent tort that such breach can constitute [an actionable tort].” Elec. Sec. Sys. Corp. v. S. Bell Tel. & Tel. Co., 482 So. 2d 518, 519 (Fla. 3d DCA 1986).

In 2013, the Florida Supreme Court held that a related doctrine — the economic loss rule — was restricted to products liability cases and could not be used to bar general commercial tort claims. Tiara Condo. Ass’n, Inc. v. Marsh & McLennan Cos., 110 So. 3d 399, 408 (Fla. 2013).

In a concurring opinion, however, Justice Pariente distinguished the independent tort doctrine as still being a valid defense in cases outside the products liability area.

The majority’s conclusion that the economic loss rule is limited to the products liability context does not undermine Florida’s contract law or provide for an expansion in viable tort claims. Basic common law principles already restrict the remedies available to parties who have specifically negotiated for those remedies, and, contrary to the assertions raised in dissent, our clarification of the economic loss rule’s applicability does nothing to alter these common law concepts. For example, in order to bring a valid tort claim, a party still must demonstrate that all of the required elements for the cause of action are satisfied, including that the tort is independent of any breach of contract claim.

Tiara Condo., 110 So. 3d at 408 (Pariente, J., concurring with opinion joined by Lewis and Labarga, JJ.).

Technically, because Justice Pariente’s concurrence was not joined by a majority of the Court, some judges have interpreted the majority ruling in Tiara as having nullified the independent tort doctrine as well as the economic loss rule outside the products liability context. See USI Ins. Services LLC v. Simokonis, 15-CV-24337, 2016 WL 11547701, at *6 (S.D. Fla. Apr. 15) (“There is some disagreement among the district courts in this Circuit on whether the independent tort rule remains intact following the Tiara decision. Some courts have cited to Justice Pariente’s concurrence in determining or at least suggesting that the independent tort rule is still applicable notwithstanding the holding of Tiara.”); report and recommendation adopted, 2016 WL 11547699 (S.D. Fla. May 13, 2016).

It was not until 2017 that the Third District Court of Appeal in Peebles v Puig, 223 So. 3d 1065 (Fla. 3rd DCA 2017), applied the independent tort doctrine for the first time since Tiara to reverse a jury verdict for commercial fraud (i.e., in a case outside the products liability context).

It is well settled in Florida that, where alleged misrepresentations relate to matters already covered in a written contract, such representations are not actionable in fraud. It is similarly well settled that, for an alleged misrepresentation regarding a contract to be actionable, the damages stemming from that misrepresentation must be independent, separate and distinct from the damages sustained from the contract’s breach. Both of these legal principles are rooted in the notion that, when a contract is breached, the parameters of a plaintiff’s claim are defined by contract law, rather than by tort law.

Peebles, 223 So. 3d at 1068 (citation omitted). The Peebles Court cited Tiara in a footnote, clarifying: “We do not evaluate this case under the economic loss rule.” Id. at 1068 n.4.

The Third DCA’s March 2020 decision in Island Travel reaffirms its commitment to apply the independent tort doctrine that it resuscitated in Peebles to bar tort claims in the commercial litigation context where there is an existing contract between the parties. Island Travel, 2020 WL 1451990, at *3 (“The only properly alleged misrepresentation simply has to do with Island’s failure to perform under the contract. It is a fundamental, long-standing common law principle that a plaintiff may not recover in tort for a contract dispute unless the tort is independent of any breach of contract.”).

The Court in Island Travel further noted that, although fraud in the inducement is generally considered to be an “independent” tort (because the misrepresentation that induces someone to enter into a contract is often unrelated to the obligations under the contract) the Plaintiff’s fraud claim in Island Travel was “clearly duplicative of its breach of contract claim [because Plaintiff] sought the exact same damages for both its fraud claim and its breach of contract claim.” Id. n.7 (emphasis added).

The takeaway: where a contract has been breached, a simultaneous common law tort claim lies only for acts deemed independent of those establishing the contract’s breach or for damages that are attributable to actions other than those that caused the breach of contract.

The litigation and corporate attorneys of Fuerst Ittleman David & Joseph have extensive experience handling complex matters throughout Florida and the United States and can assist with a full range of litigation, transactional, and compliance services from start-up to daily operations of your thriving business enterprise. Please contact us at 305-350-5690 or email us at info@fuerstlaw.com.

 

 

Contracts in the Time of Coronavirus:

Part II: Impossibility of Performance and Frustration of Purpose under Florida Law.

 

As the world braces for a prolonged battle with the coronavirus pandemic, the effects will most assuredly have wide-ranging impacts on business and contractual relationships. Business owners may be faced with labor and supply shortages, as well as government intervention, such as quarantines or emergency shelter-in-place orders, which will render non-performance of contractual duties ever the more likely. Nevertheless, in spite of the pandemic, contracts still remain valid and enforceable, and parties still face liability for breaching their contractual obligations. However, parties faced with the difficult decisions of how to fulfil contractual obligations in these unique conditions may be able to excuse their performance under several doctrines of nonperformance. In this multipart series, the commercial litigation attorneys of FIDJ explore various doctrines which may excuse performance of contractual obligations.

In part I of our series, we discussed the potential application of force majeure clauses to excuse nonperformance. To the extent a contract either does not contain a force majeure provision or the clause it does contain excludes pandemics, a party’s performance may be excused by two other related doctrines under Florida law: the doctrines of impossibility and frustration of purpose.

“[I]mpossibility of performance is a defense to nonperformance and refers to situations where the purpose for which the contract was made has become impossible to perform.” FL-Tampa, LLC v. Kelly-Hall, 135 So.3d 563, 569 (Fla. 2d DCA 2014). Generally, impossibility concerns situations where the contractual purposes, on one side, have become impossible for that party to perform. However, merely because performance has been made more difficult or expensive, it does not necessarily mean something is impossible to perform. Home Design Center—Joint Venture v. County Appliances of Naples, Inc., 563 So.2d 767, 769-770 (Fla. 2d DCA 1990).

A similar, but distinct, concept is the doctrine of “frustration of purpose,” which “refers to that condition surrounding the contracting parties where one of the parties finds that the purposes for which he bargained, and which were known to the other party, have been frustrated because of the failure of consideration or impossibility of performance by the other party.” Crown Ice Mach. Leasing Co. v. Sam Senter Farms, Inc., 174 So.2d 614, 617 (Fla. 2d DCA 1965). “‘[F]rustration of purpose’ excuses performance by a party where the value of performance regarding the subject of an agreement has been frustrated or destroyed [and] is not limited to strict ‘impossibility,’ but includes ‘impracticability’ due to unreasonable expense.” Hopfenspirger v. West, 949 So.2d 1050, 1053-1054 (Fla. 5th DCA 2006).

When applying both doctrines, courts look to whether the contingency at issue was foreseeable at the time the parties entered into the contract. If the risk was foreseeable and could have been the subject of an express contractual agreement, courts are hesitant to invoke either doctrine to excuse nonperformance. Home Design Center—Joint Venture, 563 So.2d at 769. In other words, “[u]nder the doctrine of impossibility of performance or frustration of purpose, a party is discharged from performing a contractual obligation which is impossible to perform and the party neither assumed the risk of impossibility nor could have acted to prevent the event rendering the performance impossible.” Marathom Sunsets, Inc. v. Coldiron, 189 So.3d 235, 236 (Fla. 3d DCA 2016). “If the risk of the event that has supervened to cause the alleged frustration was foreseeable there should have been provision for it in the contract, and the absence of such a provision gives rise to the inference that the risk was assumed.” American Aviation, Inc. v. Aero-Flight Service, Inc., 712 So.2d 809, 810 (Fla. 4th DCA 1998).

Thus, nonperformance will not be excused where the party seeking to raise the defense had knowledge of facts, or such facts were available to him, which make performance impossible prior to entering into the contract. Similarly, reasonably foreseeable difficulties which could have been foreseen at the time of the creation of the contract will not excuse nonperformance. Additionally, where the party seeking to raise the defense could have acted to prevent the event rendering performance impossible, a party will face difficulty in successfully asserting either doctrine.

As the coronavirus pandemic lingers, the possibility of nonperformance will continue to rise. Fuerst Ittleman David & Joseph was founded with a focus on serving the legal needs of domestic and international businesses. Indeed, our clients range from start-ups and small businesses all the way up to Fortune 500 companies. The commercial litigation practice group of Fuerst Ittleman David & Joseph has decades of experience litigating a wide array of business disputes in various forums at both the state and federal level as well as before both domestic and international arbitration panels. In addition, the corporate transactional team of FIDJ can assist your company with a full range of corporate legal services which can take you (and your company) from the initiation of your business plan through to the daily operation of your now-thriving company. For more information contact us at 305-350-5690 or contact@fidjlaw.com.

Do I have Coronavirus Insurance Coverage?

The spread of COVID-19 threatens to devastate South Florida’s economy, which relies heavily on its hospitality industry. The Miami Herald reported that as of March 18, the 150,000 hotel rooms in Miami-Dade County alone, plummeted from an occupancy rate of nearly 90 percent down to 20 percent. That number will likely approach zero as Miami-Dade County Mayor Carlos Gimenez ordered the closure of all non-essential business by March 19 at 9:00 p.m., and global travel restrictions are now in effect. These measures could last several weeks, at minimum, during an otherwise busy and profitable tourist season in South Florida. The losses to the hotel industry are expected to enter into the billions, and that does not include losses from related business, such as restaurants, bars, entertainment venues, and tour operators.

One of the only potential sources of recovery to Florida business owners may be from their insurers.  In this blog post, we review three applicable types of coverage commonly found in a business insurance policy.  Whether coverage is available will depend upon numerous factors, including the specific language of a company’s particular policy and the manner in which the courts interpret those policies.

Business Interruption Coverage

Business interruption insurance coverage is intended to protect companies against the loss of income from unexpected events that cause direct physical loss or damage.  Many standard business insurance policies do not define what constitutes a “direct physical loss” necessary to trigger coverage.  In the case of a typical disaster such as a fire or windstorm, determining whether direct physical loss or damage has occurred is generally simple, although the question of whether Hurricane Katrina caused mass flooding or wind damage became far more complex than usual.[1]  In the case of the spread of a virus such as COVID-19, this exercise is more complex.  However, a number of decisions indicate that the closure of a business due to COVID-19 may, in appropriate circumstances, constitute direct physical loss sufficient to trigger insurance coverage.

In 2005, a federal appeals court addressed the issue of whether a well contaminated by e-coli bacteria constituted a direct physical loss or property damage.[2]  The court noted that although the insurance policy did not define physical loss, it did define “property damage” as “physical injury to, destruction of, or loss of use of tangible property.”[3]  Under that standard, the court concluded that a direct physical loss or property damage could arise where the “functionality” of the property was “nearly eliminated or destroyed”, or where the property was rendered “useless or uninhabitable” as a result of the presence of the bacteria.[4]

In a foundational 1968 decision, the Colorado Supreme Court held that where gasoline infiltrated the soil in and around a building, causing it to become uninhabitable and highly dangerous to use, there was a direct physical loss within the meaning of an insurance policy.[5]  Importantly, the court rejected the notion that the physical loss or damage had to occur to the building itself, quoting the following reasoning from a California appeals court:

To accept appellant’s interpretation of its policy would be to conclude that a building which has been overturned or which has been placed in such a position as to overhang a steep cliff has not been ‘damaged’ so long as its paint remains intact and its walls still adhere to one another.  Despite the fact that a ‘dwelling building’ might be rendered completely useless to its owners, appellant would deny that any loss or damage had occurred unless some tangible injury to the physical structure itself could be detected.  Common sense requires that a policy should not be so interpreted in the absence of a provision specifically limiting coverage in this manner.[6]

         In a similar vein, courts have found a “direct physical loss” to have occurred where:

  • homes were threatened by a future rock fall from an abandoned rock quarry, which had already caused extensive damage to neighboring homes;[7]
  • there was a strong chemical odor from methamphetamine cooking by other tenants which odor entered into the insured’s leased home;[8]
  • cat urine odor entered the insured’s condominium unit from a neighboring unit;[9]and
  • asbestos was released into a building.[10]

In each of these cases, the court reasoned that the direct physical loss or property damage arose from the harm or risk of harm that rendered the subject property unusable or uninhabitable in some way.

From these cases, a compelling argument can be made that where the spread or potential spread of COVID-19 renders a business premises unusable or uninhabitable for a period of time, business interruption loss coverage may be triggered.  There are of course cases that do not follow the decisions referred to above, and the success of this argument will depend on applicable state law.  At present, we are unaware of any Florida court that has adjudicated an analogous claim.[11]

Aside from variations in state law, whether a business’s insurance policy covers losses arising from its inability to use its business premises will depend on the language of its specific policy.  Some policies may have language that requires damage to specific property.  Others may exclude coverage for claims arising from communicable diseases.[12] For these reasons, business owners must carefully review its policies and obtain proper legal advice concerning the availability of business interruption coverage.

Contingent Business Interruption

Many insurance policies also contain contingent business interruption coverage that applies to damage which not only affects the company’s own property but also that of third-parties, such as its customers, suppliers, and delivery personnel.  This coverage ordinarily requires the same direct physical loss or property damage to trigger coverage as under the standard business interruption coverage, with the key difference being that the loss or damage is sustained to the third-party’s property as opposed to that of the policyholder.  Again, the applicability of this coverage is policy specific and therefore requires a careful review of the policy and advice from a competent professional.

Government Authority Coverage

Insurance policies also routinely contain coverage for losses arising when an insured cannot access its own property because of an order made by a government authority, such as Mayor Gimenez’s recent order closing all non-essential businesses.

Under most insurance policies, the government authority must completely block access to the business premises for this coverage to apply.  For this reason, Mayor Giminez’s initial orders limiting businesses’ operations likely does not trigger this type of coverage.  However, Mayor Gimenez’s more recent order for the complete closure of all non-essential businesses likely does, subject to any applicable exclusions.

Preserve Your Claims

It is important that you take steps to immediately review all of your company’s insurance policies with competent professional advisors, notify your insurer of all of your claims, and keep track of all of your losses and expenses as a result of COVID-19.  Taking these steps may mean the difference between obtaining complete coverage for your losses or bearing the entirety of them on your own.

We are currently reviewing insurance policies on behalf of for our clients across North America in the hospitality, real estate, retail and manufacturing sectors in preparing to challenge insurers who deny claims for the substantial losses they are only starting to suffer.  If you have any questions concerning your potential policy coverage for business interruption losses, feel free to contact us at 305-350-5690 or info@fidjlaw.com

 

________________________

[1]  State Farm v. United States, ex rel. Rigsby, 137 S.Ct. 436 (2016)

[2] Motorists Mutual Ins. Co. v. Hardinger, 131 Fed.Appx. 823 (3d Cir. 2005).

[3] Id., at 825.

[4] Id., at 826-827, citing Port Authority of New York & New Jersey v. Affiliated FM Ins. Co., 311 F.3d 226 (3d Cir. 2002).

[5] Western Fire Insurance Co. v. First Presbyterian Church, 165 Colo. 34 (1968).

[6] Id. at 40, quoting from Hughes v. Potomac Insurance Company, 199 Cal.App.2d 239 (1989) (emphasis added).

[7] Murray v. Sate Farm Fire and Cas. Co., 203 W.Va. 477 (1998).

[8] Farmers Insurance Co. of Oregon v. Trutanich, 858 P.2d 1332 (Or. Ct. App. 1993).

[9] Mellin v. N. Sec. Ins. Co., 115 A.3d 799 (N.H. 2015).  Notably, the court found that property damage included “not only tangible changes to the property that can be seen or touched” but also “changes that are perceived by the sense of smell and that exist in the absence of structural damage.”

[10] Port Authority of New York & New Jersey v. Affiliated FM Insurance Co., 311 F.3d 226 (3d Cir. 2002).

[11] In June of 2018, the District Court for the Southern District of Florida ruled that debris accumulating into a restaurant from neighboring road construction did not constitute direct physical loss or damages.  See Mama Jo’s, Inc. v. Sparta Insurance Company, 2018 WL 3412974 (S.D. Fla. June 11, 2018).  In so doing, the court did not decide whether to adopt a more “expansive definition” of the phrase “direct physical loss”, as set forth in the cases noted above.  Importantly though, the Court noted that even under the expansive definition, there was no such loss because the restaurant was not rendered uninhabitable as a result of the debris; it simply had incurred additional time and expense cleaning the debris.

[12] Following the SARS outbreak in 2003, many insurers began implementing such exclusions.

Contracts in the Time of Coronavirus:

Part I: Force Majeure

            As the world braces for a possible prolonged battle with the coronavirus pandemic, the effects will most assuredly have wide-ranging impacts on business and contractual relationships. Business owners may be faced with labor and supply shortages, as well as government intervention, such as quarantines or emergency shelter-in-place orders, which will render non-performance of contractual duties ever the more likely. Despite the pandemic, contracts still remain valid and enforceable, and parties still face potential liability for breaches. However, for those faced with the difficult decisions of how to fulfill contractual obligations, these generational conditions may be able to excuse their performance under several doctrines of nonperformance. In this multipart series, the commercial litigation attorneys at FIDJ explore various doctrines which may excuse performance of contractual obligations. Part I of this series explores force majeure clauses.

Any party anticipating that it will not be able to perform its duties under a contract as a result of the pandemic should immediately look to their written contract to see if a force majeure clause is present and whether it applies under these circumstances. Generally, a force majeure clause is “a contractual provision allocating the risk of loss if performance becomes impossible or impracticable, especially as a result of an event or effect that the parties could not have anticipated or controlled.” Black’s Law Dictionary, 718 (9th ed. 2009). Phrased differently, force majeure clauses alleviate one or both of the parties from some or all of their obligations to perform under a contract when an unforeseen event beyond the parties’ control prevents or delays performance.

Broadly, a force majeure clause may contain: i) an exclusive list of events constituting qualifying events; ii) a non-exclusive list with broad catch-all language (for example “and any other event beyond the anticipation or control of the parties;” or iii) a general definition of force majeure with no list of qualifying events. When interpreting force majeure clauses, courts begin with the plain language of the contract itself, and construe the clauses narrowly.

In cases where express/exclusive language is used, courts hesitate to construe the clause beyond its own terms. This type of force majeur clause might feature a specific list of events, the occurrence of any of which would excuse a party from its obligation to perform under the obligation. To the extent a contract contains a non-exclusive list, which might describe those events in more general terms, courts analyze whether the claimed event, here a pandemic, is of the same nature as the events listed. In the final case, courts tend to evaluate whether the claimed event was reasonably foreseeable. The more likely an event was reasonably foreseeable, the less likely an excuse for nonperformance based on force majeure will be sustained. We also note that not only will contractual language determine what events are covered, it may also determine whether unanticipated events which merely delay performance, rather than making such performance impossible, are excused.

Determining whether a force majeure clause applies must occur on a case-by-case basis. In all cases, parties seeking to rely upon a force majeure clause, as well as those parties receiving notice of another party to a contract seeking to enforce such a provision, should take the following steps:

1) review the force majeure provision’s language to determine its breadth and whether the claimed event is, or could be argued to be, covered by the provision;
2) determine the governing law of the contract;
3) determine whether non-performance is linked to a claimed force majeure event or if subsequent actions also contributed to nonperformance;
4) determine whether the contract requires prior notice and, if so, whether the required notice was properly given;
5) determine what obligations of both the claiming party and non-claiming party are tolled (i.e. are payments of the non-claiming party tolled? What about exclusivity provisions?);
6) determine whether the contract provides a duty to mitigate such that a claiming party needs to take/demonstrate other efforts to satisfy the contract before performance can be excused by a force majeure clause.

           As the coronavirus pandemic lingers, the possibility of nonperformance will continue to rise. Please contact us if you have any questions about any of these issues, as we will be working throughout this crisis, and advising our clients regarding their existing contracts, the consequences of non-performance, and how to prepare for an uncertain future. Feel free to contact us at 305-350-5690 or info@fidjlaw.com.

Seventeenth Judicial Circuit Appoints Judge Bowman as Circuit’s First Appellate Division Chair

The following article was written by Jeffrey J. Molinaro for the March 2020 issue of the Broward County Bar Association’s Barrister Magazine. A full copy of the edition is available here. Mr. Molinaro is a proud member of the Broward County Bar Association.

On January 29, 2020, the Seventeenth Judicial Circuit announced a restructuring of its Appellate Division. As part of this restructuring process, Circuit Judge John Bowman was appointed by Chief Judge Jack Tuter as the division’s first Appellate Chair.

Pursuant to Article V, § 5(b) of the Florida Constitution, the circuit courts of Florida have appellate jurisdiction when provided by general law. The scope of the circuit courts’ appellate jurisdiction is found at § 26.012(1), Florida Statutes. The Appellate Division’s restructuring comes as it braces for a potential increase in appeals as a result of the legislature’s expansion of the County Court’s jurisdictional limit of $15,000 to $30,000, which became effective January 1, 2020.

As currently composed, the Appellate Division hears appeals of County Court decisions in three judge panels. However, circuit judges are neither permanently nor exclusively assigned to the Appellate Division. Instead, circuit judges are appointed to appellate panels on a six-month rotation. Previously, the Circuit relied upon court staff to oversee the Appellate Division. However, due to the potential influx of additional appellate cases, the rotation of appellate panel members, and to ensure consistency within and supervision over the Appellate Division, a permanent judicial chair was created to oversee the division. The appointment of a permanent chair is designed to allow the Court to continue to handle County to Circuit appeals in an efficient manner despite an increase in caseload which might arise.

The Appellate Division’s restructuring comes at a time when County to Circuit appeals have come under increased scrutiny due to the lack of uniformity in the County to Circuit appeals process across the state. Critics of the County to Circuit appeals process have focused on three areas: i) the lack of uniformity in the use of three judge panels instead of single judges to hear such appeals; ii) the fact that not all circuits publish their appellate opinions either online or within Florida Law Weekly; and iii) circuit appellate rulings are not binding on other circuit panels; thus, intra- as well as inter-circuit conflicting decisions occur. (It should be noted that the Seventeenth Judicial Circuit both uses three judge panels and publishes its opinions on its website.)

As a result of these deficiencies, in its 2017 regular-cycle report, the Florida Bar’s Appellate Court Rules Committee proposed amending rule 9.030 (Jurisdiction of Courts) of the Florida Rules of Appellate Procedure to require that all circuit courts adopt three judge panels. However, the Florida Supreme Court rejected this proposal. Instead, the Court created a workgroup to research these issues and propose substantive changes if necessary. Ultimately, the workgroup recommended that the legislature pass legislation to strip the circuit courts of jurisdiction over county court appeals and instead have such appeals heard by the District Courts of Appeal. While no legislation is pending, the Florida Supreme Court endorsed the workgroup’s recommendation on November 8, 2019.

A lifelong Broward County resident and graduate of Florida Atlantic University and St. Thomas University School of Law, Judge Bowman was first elected to the Circuit Court in 2002. Judge Bowman currently serves in the Circuit Civil Division. In announcing Judge Bowman’s appointment, Chief Judge Tuter explained that Judge Bowman will serve as chair of the Appellate Division while continuing his full-time civil trial duties. We wish Judge Bowman success in his new endeavor.

Ex-Boca school counselor who pushed fentanyl spray for Insys is heading to prison

By John Pacenti
January 23, 2020

Alec Burlakoff was the sales mastermind of a conspiracy to pay doctors “speakers fees” so they would prescribe Subsys in higher amounts and greater doses.

Alec Burlakoff — the one-time Boca Raton high school counselor who masterminded a bribery scheme to get doctors to prescribe a potent fentanyl spray — was sentenced to 26 months in prison on Thursday in a Boston courtroom, benefiting from flipping against the owner of the company.

Burlakoff, 45, had a checkered past at previous pharmaceutical companies before helping turn Arizona-based Insys Therapeutics into a Wall Street juggernaut, birthing his bribery scheme in South Florida.

As vice president of sales, he recruited strippers, waitresses and cheerleaders to be sales reps to lure doctors into prescribing the deadly fentanyl spray Subsys by paying them for bogus speaking engagements. He and Insys funneled $16.3 million into doctors’ pockets over 2½ years.

All of this occurred as the nation struggled in the grip of a crippling opioid crisis. As a result, Insys became the subject of a congressional hearing and its own episode on CNBC’s “American Greed.”

“I didn’t think of who we were at Insys, and how unethical what we were doing was,” Burlakoff told U.S. District Judge Allison Burroughs in Boston on Thursday. “The only thing I could think was how could I keep up with the fast and furious pace necessary to get ahead.”

Burlakoff’s metamorphosis to hapless victim of greedy Big Pharma was belied by the fact he once bragged that he took his sales tactics from the movie “The Wolf of Wall Street.”

He also dressed up as a giant bottle of Subsys for a rap video played at a sales conference. The video urged Insys sales reps to get doctors to prescribe fentanyl at the highest, most addictive dose.

Burlakoff threatened to fire any rep who could not get their doctors to write at least one script per day, according to a federal lawsuit.

The higher the dose, the more money Insys made for a drug that costs $1,800 retail for 30 spray bottles at its lowest strength and as much as $6,000 at its highest dose.

Insys made $500 million in 2014 and 2015 under Burlakoff’s guidance. Subsys sales rose 3,200 percent. The company filed for bankruptcy in 2019.

“This was an offense of greed,” Burroughs said. The judge previously called Burlakoff one of the “co-architects” of the Insys bribery and fraud conspiracy.

Burroughs told Burlakoff he will have “to live with the fact that some of these other people got swept into this because you recruited them.” She then gave him six more months than prosecutors requested.

What was missing in Burlakoff’s sentencing were the patients who suffered immeasurably under the addictive drug. At least 908 patients died with Subsys the primary suspect in their deaths, The Palm Beach Post reported in its multipart 2018 investigation, “Pay to Prescribe: The Fentanyl Scandal.”

The fentanyl spray was approved by the FDA only for cancer pain, but doctors under the Burlakoff plan prescribed the spray for routine back pain, migraines and intestinal disorders.

Prosecutors asked Burroughs to “hold your nose” and give Burlakoff a 20-month sentence, far less than other executives and doctors in the scandal, because he had testified at trial against Insys’ owner and chairman, John Kapoor, who got 5½ years in prison Thursday.

“The conduct of the Insys’ executives was nothing short of evil, Alec Burlakoff being a central actor,” said attorney Richard Hollawell, who is suing Insys on behalf of a family who lost a daughter, Sarah Fuller, to Subsys.

“I do commend him for being the first to step up and cooperate. His cooperation helped with Kapoor’s conviction and those of many others.”

Unlike in the Burlakoff sentencing, seven victims and family members of victims who were prescribed the spray gave emotional statements to the court concerning Kapoor.

“Far too many people have died, or like me, have had their lives changed, at the hands of your greed and cruelty,” said one victim, Paul Lara. “It’s unrealistic to believe that Insys Therapeutics executives could not see the results of their behavior.”

Burlakoff certainly got off easy considering that the judge called him one of the “co-architects” of the bribery and fraud conspiracy.

Other executives, even those who pleaded out, received sentences between 27 and 33 months.

Sunrise Lee — a West Palm Beach stripper turned Insys sales Siren — was sentenced to a year in prison on Wednesday. She once gave a doctor a lap dance and she was a regional sales manager for Insys.

Doctors have also been prosecuted. Leading the pack are Alabama’s Dr. Xiulu Ruan and John Patrick Couch. They are serving 21- and 20-year prison sentences for their role in promoting Subsys and other opioid scams.

Florida doctors, some who netted hundreds of thousands of dollars in speaker fees, have largely escaped the wrath of federal prosecutors.

Insys paid Florida physicians more than $2.1 million from August 2013 through 2015 The Post analysis of Medicare data showed. Florida topped the nation for Subsys claims in 2014 and 2015.

Burlakoff brought the sham speaker programs from his previous job at Cephalon, which settled with the Justice Department for $425 million for pursuing off-label prescriptions of its fentanyl lollipop and two other drugs.

Before that, he was fired from Eli Lilly and Co., a pharmaceutical giant, and as a sales rep in Palm Beach and Broward counties. He and two other salespeople sent unsolicited Prozac through the mail.

But Burlakoff attorneys and supporters told the judge the man who once counseled teens and coached them at basketball at Pine Crest School in Boca lost his way when his brother committed suicide by cop after gunning down his wife on a Boca Raton street.

In a letter to the judge, a friend of Burlakoff’s said after his brother’s death “his thinking was a little out of whack.”

“This shocking trauma took place in October 2013 when Mr. Burlakoff was in the midst of the conspiracy at Insys,” attorney Joshua Ruby wrote in a sentencing memorandum. “Tellingly, Dr. Kapoor ordered Mr. Burlakoff to return to work after only a matter of days of grieving.”

Burlakoff caved to Kapoor’s win-at-all-cost culture at Insys, Ruby told the court, and “let his drive and competitiveness — which had served him so well as a coach — overcome his judgment.”

Burlakoff pleaded guilty to a single count of racketeering conspiracy in November 2018, setting up his dramatic testimony in Kapoor’s trial.

Federal prosecutors in Boston used a landmark approach, charging Insys executives under the Racketeer Influenced and Corrupt Organizations Act. RICO is a charge often reserved for mob bosses and drug lords.

Miami attorney Andrew Ittleman said for years opioid companies operated with impunity in breaking the law.

The Insys prosecutions, Ittleman said, “may very well be a bellwether for future prosecutions in the opioid industry, especially as the public learns more about it on an almost daily basis,” he said.

Bloomberg and USA TODAY contributed to this story.

Click here to view the original article.